218 related articles for article (PubMed ID: 20880389)
1. Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.
Kast RE
Br J Pharmacol; 2010 Oct; 161(3):481-7. PubMed ID: 20880389
[TBL] [Abstract][Full Text] [Related]
2. 5-HT6 receptor ligands and their antipsychotic potential.
Arnt J; Olsen CK
Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
[No Abstract] [Full Text] [Related]
3. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
4. The serotonin-7 receptor as a novel therapeutic target.
Stahl SM
J Clin Psychiatry; 2010 Nov; 71(11):1414-5. PubMed ID: 21114946
[TBL] [Abstract][Full Text] [Related]
5. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
6. Do loxapine plus cyproheptadine make an atypical antipsychotic? PET analysis of their dopamine D2 and serotonin2 receptor occupancy.
Kapur S; Zipursky RB
Arch Gen Psychiatry; 1998 Jul; 55(7):666-8. PubMed ID: 9672060
[No Abstract] [Full Text] [Related]
7. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.
Elmaci I; Altinoz MA
Crit Rev Oncol Hematol; 2018 Aug; 128():96-109. PubMed ID: 29958636
[TBL] [Abstract][Full Text] [Related]
8. The role of serotonin in antipsychotic drug action.
Meltzer HY
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):106S-115S. PubMed ID: 10432496
[TBL] [Abstract][Full Text] [Related]
9. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
Terrón JA
Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
[No Abstract] [Full Text] [Related]
10. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants.
Levy AD; Van de Kar LD
Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027
[TBL] [Abstract][Full Text] [Related]
12. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
He H; Richardson JS
Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676
[TBL] [Abstract][Full Text] [Related]
13. 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment.
Rossé G; Schaffhauser H
Curr Top Med Chem; 2010; 10(2):207-21. PubMed ID: 20166958
[TBL] [Abstract][Full Text] [Related]
14. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
15. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
[TBL] [Abstract][Full Text] [Related]
16. Effects of antipsychotic drugs on serotonin receptors.
Meltzer HY; Nash JF
Pharmacol Rev; 1991 Dec; 43(4):587-604. PubMed ID: 1685568
[No Abstract] [Full Text] [Related]
17. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
18. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
19. Current and novel approaches to the drug treatment of schizophrenia.
Rowley M; Bristow LJ; Hutson PH
J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639
[No Abstract] [Full Text] [Related]
20. Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
Dremencov E; El Mansari M; Blier P
Psychopharmacology (Berl); 2007 Sep; 194(1):63-72. PubMed ID: 17530476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
